Behring sales up 16% despite economic climate:
This article was originally published in Clinica
Executive Summary
Behring Diagnostics, a subsidiary of German group Hoechst, has reported a 16% sales increase to DM 930 million ($620 million) in 1996. Sales in Behring's main markets - the US, Germany and Japan - continue to be hit by cost-cutting measures and the poor economic climate. However, significant growth was achieved in the rest of Asia, the Middle East and Eastern Europe. In March, Behring Diagnostics and Dade International announced their intention to merge. The companies are awaiting approval from the US and European authorities (see Clinica No 748, p 1).